Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Immunochemotherapie des metastasierenden uvea-melanoms mit interferon- α2b, interleukin-2 und fotemustin: Kasuistiken und literaturubersicht
Translated title of the contribution
:
Imunochemotherapy of metastatic uveal melanoma with interferon-α2b, interleukin-2, and fotemustine: Case reports and literature review
Patrick Terheyden
, Eckhart Kämpgen, Thomas M. Rünger, Eva Bettina Bröcker, Jürgen C. Becker
*
*
Corresponding author for this work
Clinic of Dermatology, Allergology and Venerology
University of Würzburg
Georg August University Göttingen
19
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Imunochemotherapy of metastatic uveal melanoma with interferon-α2b, interleukin-2, and fotemustine: Case reports and literature review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Uvea Melanoma
100%
Metastatic Uvea Melanoma
100%
Interleukin 2
100%
Fotemustine
100%
Neoplasm
66%
Metastatic Carcinoma
66%
Lymph Node Metastasis
33%
Disease Exacerbation
33%
Immunoglobulin
33%
Nursing and Health Professions
Interferon
100%
Interleukin 2
100%
Metastatic Uvea Melanoma
100%
Fotemustine
100%
Cutaneous Melanoma
66%
Immunoglobulin
33%
Disease Exacerbation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 2
100%
Metastatic Uvea Melanoma
100%
Fotemustine
100%
Cutaneous Melanoma
66%
Neoplasm
66%
Immunoglobulin
33%
Lymph Node Metastasis
33%